Annotated Bibliography Week 4 Final Assignment
Annotated Bibliographyweek 4 Final Assignment Annotated Bibliographyn
This assignment requires creating an APA-formatted annotated bibliography from four sources related to sarcoidosis, including a summary and an assessment of each source’s reliability. The bibliography should include citations, 50-word summaries, and 50-word assessments of trustworthiness, all aligned with APA standards. An APA title page with the research question as the title is also required. The objective is to critically evaluate sources to support research on sarcoidosis, with clear, structured annotations to demonstrate understanding and credibility assessment.
Paper For Above instruction
Understanding sarcoidosis is crucial for advancing diagnosis, treatment, and patient management strategies. This annotated bibliography synthesizes four scholarly and authoritative sources, providing concise summaries and validity assessments, to establish a reliable foundation for research on sarcoidosis.
The first source, by Milman et al. (2003), investigates the application of FDG PET scans in monitoring pulmonary sarcoidosis during corticosteroid therapy. The study highlights the diagnostic utility of PET imaging in assessing disease activity and response to treatment, emphasizing its importance in clinical management. The research's robust methodology, including imaging techniques and patient follow-up, strengthens its reliability, though the specificity of PET scans remains subject to further validation. Its publication in Respiration, a reputable journal, underscores its scholarly credibility.
The second source, by Morgenthau and Teirstein (2011), offers a comprehensive review of sarcoidosis affecting the upper and lower airways. The article synthesizes current knowledge on pathophysiology, clinical presentation, and therapeutic approaches, providing a valuable overview for clinicians. Its thorough literature review and expert authorship support its reliability. As a publication in the Expert Review of Respiratory Medicine, it also underscores its credibility in the respiratory medicine field.
The third source, from the National Heart, Lung, and Blood Institute (2013), provides an authoritative overview of sarcoidosis characteristics, causes, and general information. Serving as a governmental health resource, this accessible and evidence-based source offers reliable, up-to-date details suitable for foundational understanding. Its credibility is reinforced by adherence to NIH standards, although it lacks detailed clinical study data, which is appropriate for overview purposes.
The fourth source from Ohio State University Wexner Medical Center (N.D.) details pulmonary sarcoidosis, including symptoms, diagnosis, and management strategies. As a university medical center publication, it provides a practical, clinical perspective grounded in current best practices. While not peer-reviewed research, its institutional backing ensures a credible, patient-focused overview, though its general nature means it should be supplemented with scholarly research for academic purposes.
References
- Milman, N., Mortensen, J., & Sloth, C. (2003). Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids. Respiration, 70(4), 408-413.
- Morgenthau, A. S., & Teirstein, A. S. (2011). Sarcoidosis of the upper and lower airways. Expert Review of Respiratory Medicine, 5(6), 823–833.
- National Heart, Lung, and Blood Institute. (2013). What is Sarcoidosis? Retrieved from https://www.nhlbi.nih.gov/health-topics/sarcoidosis
- Ohio State University Wexner Medical Center. (N.D.). Pulmonary Sarcoidosis. Retrieved from https://wexnermedical.osu.edu/medical-care/pulmonary-sarcoidosis
This annotated bibliography synthesizes pertinent, credible sources that provide both clinical and research insights into sarcoidosis. The detailed evaluations of source reliability ensure the foundation for further research is both solid and trustworthy, supporting a comprehensive understanding of this complex disease.